Influence Of The Number Of Platelets And Hemoglobin Concentrations In Predicting The Development Of Proteinuria Induced By The Administration Of Bevacizumab

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disesase. Nature Medicine 1995;1:27-31.10.1038/nm0195-277584949Search in Google Scholar

2. Jain RK, “Molecular Regulation of Vessel Maturation,” Nature Medicine 2003; 9:685-693.10.1038/nm0603-68512778167Search in Google Scholar

3. Ferrara N. Vascular endothelial growth factor and the regulation of angiogenesis. Department of Molecular Oncology. 2000; 55:15-35.Search in Google Scholar

4. Dunst, J., Pigorsch, S., Hansgen, G., Hintner, I., Lautenschlager, C., Becker, A. Low hemoglobin is associated with increased levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anemia stimulate angiogenesis? Strahlenther Onkologie. 1999; 175: 93-96.10.1007/BF0274234010093609Search in Google Scholar

5. Gerber H, Condorelli F, Park J, Ferrara N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. Journal of Biological Chemistry 1997; 272: 23659-67.10.1074/jbc.272.38.236599295307Search in Google Scholar

6. Katoh O, Tauchi H, Kawaishi K, Kimura A, Satow Y. Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Research 1995; 55(23):5687-92.Search in Google Scholar

7. Battinelli EM, Markens BA, Italiano JE. Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiological and pathological angiogenesis. Blood. 2011;118(5):1359-69.10.1182/blood-2011-02-334524315250021680800Search in Google Scholar

8. Carmeliet P., Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000; 407(6801): 249-57.10.1038/3502522011001068Search in Google Scholar

9. Poon RT-P, Fan S-T, Wong J. Clinical implications of circulating angiogenic factors in cancer patients. Journal of Clinical Oncology 2001; 19(4): 1207–25.10.1200/JCO.2001.19.4.120711181687Search in Google Scholar

10. Jain RK. Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nature Medicine 2001; 7(9): 987-9.10.1038/nm0901-98711533692Search in Google Scholar

11. FDA Approval for Bevacizumab. National Cancer Institute. (Accessed in May 2013 at http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab)Search in Google Scholar

12. SPC Avastin (Accessed in Sep 2012 at http://www.medicines.org.uk/emc/medicine/15748)Search in Google Scholar

13. Abbate M, Zoja C, Remuzzi G. How Does Proteinuria Cause Progresive Renal Damage? Journal of the American Society of Nephrology 2006; 17(11): 2974-84.Search in Google Scholar

14. Loon NR. Diabetic Kidney Disease: Preventing Dialysis and Transplantation. Clinical Diabetes 2003; 21(2): 55-62.10.2337/diaclin.21.2.55Search in Google Scholar

15. Clinical Research Protocols. National Institutes of Health. (Accessed in June 2012 at http://www.niehs.nih.gov/about/od/ethics/protocols/)Search in Google Scholar

16. Harshman LC, Kuo CJ, Wong BY, Vogelzang NJ, Srinivas S. Increased hemoglobin associated with VEGF inhibitors in advanced renal cell carcinoma. Cancer Investigation. 2009 Oct; 27(8):851-6.10.1080/0735790090274452819603304Search in Google Scholar

17. Mutlu H, Berk V, Karaca H, Erden A, Aslan T, Akca Z. Treatment Regimen With Bevacizumab Decreases Mean Platelet Volume in Patients With Metastatic Colon Cancer. Clinical and Applied Thrombosis/Hemostasis 2012; 18 (5): 546-548.10.1177/107602961143095822203035Search in Google Scholar

18. DiLeo A, Messa C, Russo F, et al. Prognostic value of cytosolic estrogen receptors in human colorectal carcinoma and surrounding mucosa: preliminary results. Dig Dis Sci. 1994;39:2038-2042.10.1007/BF020881448082515Search in Google Scholar

19. Heon Seo K, Lee HS, Jung B, et al. Estrogen Enhances Angiogenesis through a Pathway Involving Platelet-Activating Factor-Mediated Nuclear Factor-KB Activation. Cancer Research 64, 2004; 6482-6488.10.1158/0008-5472.CAN-03-277415374958Search in Google Scholar

20. Witte D, Chirala M, Younes A, Li Y and Younes M: Estrogen receptor beta is expressed in human colorectal adenocarcinoma. Human Pathology 2001;32: 940-944.10.1053/hupa.2001.2711711567223Search in Google Scholar

21. Hendifar A, et al. Gender Disparities in Metastatic Colorectal Cancer Survival. Clinical Cancer Research 2009; (15): 6391.10.1158/1078-0432.CCR-09-0877277976819789331Search in Google Scholar

22. Schmetzer O, Flörcken A. Sex differences in the drug therapy for oncologic diseases. Handbook of Experimental Pharmacology. 2012;(214):411-42.10.1007/978-3-642-30726-3_1923027461Search in Google Scholar

23. Wakelee HA, Dahlberg SE, Brahmer JR, et al.: Differential effect of age on survival in advanced NSCLC in women versus men: analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumab. Lung Cancer 76, 2012;(3): 410-5.10.1016/j.lungcan.2011.12.006346063922266041Search in Google Scholar

24. Cassidy J, Saltz LB, Giantonio BJ, Kabbinavar FF, Hurwitz HI, Rohr UP. Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies. Journal of Cancer Research and Clinical Oncology 2010; 136(5): 737-743.10.1007/s00432-009-0712-3284175519904559Search in Google Scholar